Fassler, MirjamBerner, FiammaAkdis, MubeccelFlatz, LukasVan De Veen, Willem2024-06-262024-06-262021-08-010014-2980https://hdl.handle.net/11452/42455eninfo:eu-repo/semantics/closedAccessB lymphocytesBiomarkersCancer immunologyCheckpoint inhibitionImmune response tracingImmunotherapyScience & technologyLife sciences & biomedicineImmunologyImmunologyCharacterization of b cell responses during checkpoint immunotherapy in metastatic melanomaMeeting Abstract00075336640220741441451Supplement 1